España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Amphastar Pharma
AMPH
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$31.28
-0.02
-0.06%
At close: -
$31.28
0.00
0.00%
After Hours: Feb 21, 4:00 PM EDT
Get Report
Comment
Q4 2024 Earnings in 5 days from now on Thu Feb 27th, after the market close
Amphastar Pharma (AMPH) Forecast
News
Earnings
Amphastar Pharma (AMPH) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Amphastar Pharma (NASDAQ:AMPH) Stock
Amphastar Pharma Stock (NASDAQ: AMPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 21, 2025
Top 2 Health Care Stocks That May Rocket Higher This Month
Avi Kapoor
Tuesday, February 04, 2025
This Ollie's Bargain Outlet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Avi Kapoor
Piper Sandler Downgrades Amphastar Pharma to ...
Benzinga Newsdesk
Thursday, November 07, 2024
Amphastar Pharma shares are trading lower aft...
Benzinga Newsdesk
Wednesday, November 06, 2024
Amphastar Pharmaceuticals Expands Share Buyba...
Benzinga Newsdesk
Amphastar Pharma Q3 2024 Adj EPS $0.96 Misses...
Benzinga Newsdesk
Friday, September 06, 2024
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
Vandana Singh
Thursday, August 08, 2024
Amphastar Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Needham Reiterates Hold on Amphastar Pharma
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Amphast...
Benzinga Newsdesk
Wednesday, August 07, 2024
Amphastar Pharma Q2 Adj $0.94 Beats $0.77 Est...
Benzinga Newsdesk
Thursday, June 27, 2024
Piper Sandler Reiterates Overweight on Amphas...
Benzinga Newsdesk
Tuesday, June 04, 2024
Amphastar Pharmaceuticals Authorized A $50M I...
Benzinga Newsdesk
Wednesday, May 22, 2024
Needham Reiterates Hold on Amphastar Pharma
Benzinga Newsdesk
Amphastar Bags FDA Approval for Albuterol Sul...
Benzinga Newsdesk
Thursday, May 09, 2024
Needham Reiterates Hold on Amphastar Pharma
Benzinga Newsdesk
Wednesday, May 08, 2024
Amphastar Pharma Q1 2024 Adj EPS $1.04 Beats ...
Benzinga Newsdesk
Wednesday, May 01, 2024
Federal Trade Commission Targets 'Junk Patent Listings' For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca
Vandana Singh
Wednesday, April 10, 2024
Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies
Vandana Singh
Needham Reiterates Hold on Amphastar Pharma
Benzinga Newsdesk
Tuesday, March 05, 2024
JP Morgan Initiates Coverage On Amphastar Pha...
Benzinga Newsdesk
Thursday, February 29, 2024
Amphastar Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Wednesday, February 28, 2024
Amphastar Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Amphastar Pharma Q4 EPS $0.88 Misses $0.91 Estimate, Sales $178.10M Beat $175.67M Estimate
Happy Mohamed
Earnings Scheduled For February 28, 2024
Benzinga Insights
Tuesday, February 27, 2024
Earnings Outlook For Amphastar Pharma
Benzinga Insights
Friday, January 19, 2024
What Vitamins Did For Healthy Living, Stemtech Corporation (OTCQB: STEK) Says It Is Doing For Anti-Aging With Stem Cell Nutrition
Meg Flippin
-
Sponsored
Wednesday, January 17, 2024
Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive'
Avi Kapoor
Tuesday, November 21, 2023
Amphastar Pharma Insider Trades Send a Signal
Benzinga Insights
Friday, November 17, 2023
B of A Securities Initiates Coverage On Ampha...
Benzinga Newsdesk
Thursday, November 09, 2023
Amphastar Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Disney, Twilio, TransDigm, Marathon Digital And Other Big Stocks Moving Higher On Thursday
Lisa Levin
Wednesday, November 08, 2023
Amphastar Pharma Q3 Adj EPS $1.15 Beats $0.69...
Benzinga Newsdesk
Recap: Amphastar Pharma Q3 Earnings
Benzinga Insights
Earnings Scheduled For November 8, 2023
Benzinga Insights
Tuesday, November 07, 2023
Earnings Preview For Amphastar Pharma
Benzinga Insights
Wednesday, September 13, 2023
Amphastar Pharmaceuticals Prices Offering Of ...
Benzinga Newsdesk
Tuesday, September 12, 2023
Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Monday, September 11, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Tuesday, August 22, 2023
Board Member At This Health Care Company Sells $105K of Stock
Benzinga Insights
Thursday, August 17, 2023
Amphastar Pharma Recent Insider Activity
Benzinga Insights
Board Member of Amphastar Pharma Sold $730K In Stock
Benzinga Insights
Tuesday, August 08, 2023
Amphastar Pharma Q2Adj EPS $0.65 Beats $0.56...
Benzinga Newsdesk
Earnings Scheduled For August 8, 2023
Benzinga Insights
Tuesday, July 25, 2023
Jefferies Reinstates Buy on Amphastar Pharma,...
Benzinga Newsdesk
Thursday, June 22, 2023
Amphastar Pharma EVP Acquires 9,651 Shares After Exercising Company Stock Options
Benzinga Insights
Thursday, June 15, 2023
Amphastar Pharma EVP Acquires 5,000 Shares After Exercising Company Stock Options
Benzinga Insights
Wednesday, May 17, 2023
Amphastar Pharma Director Trades Company's Stock
Benzinga Insights
Amphastar Pharma Board Member Acquires 10,000 Shares After Exercising Company Stock Options
Benzinga Insights
Wells Fargo Maintains Equal-Weight on Amphast...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
